Pii to double sterile capacity in Maryland site expansion

- Last updated on GMT

Pharmaceutics International, Inc (Pii) is to double its sterile GMP production capacity by building a 24,000 sq ft facility.

Construction of the facility in Maryland, US will strengthen Pii in the growth areas of oncology and high potency compounds by giving it more fill/finish suites for handling vials and syringes.

The additional facilities will enable us to support our clients from pre-clinical through commercial-scale production and meet the growing demand for fill/finish services for potent compounds and oncology drugs​”, Steve King, senior vice president of Pii, said.

Pii expects to complete construction of the facility in the fourth quarter of 2012.

Related topics: Contract Manufacturing

Related news